CompuMed Announces Contracts to Provide Remote ECG Screening and Cardiologist Over-Reads for Correctional Facilities in Arizo...
10 Septembre 2012 - 3:25PM
Marketwired
CompuMed, Inc. (OTCBB: CMPD)
(www.compumed.net) -- a leader in telemedicine services for patient
diagnosis and management -- today announced that it has signed
statewide contracts in conjunction with Wexford Health Sources,
Inc. CompuMed will provide CardioGram™ electrocardiogram (ECG)
remote interpretation systems and cardiologist over-read services
to all state-operated locations within the Arizona Department of
Corrections and Maryland Department of Public Safety &
Correctional Services. Under terms of both the contracts,
CompuMed's CardioGram systems will be used to perform telemedicine
enabled remote cardiac screening for detainees at the states'
correctional facilities.
"We value our association with Wexford Health as the company
delivers high quality care to its correctional customers," said
Maurizio Vecchione, CompuMed's CEO. CompuMed is a preferred
value-added partner of Wexford Health. Based in Pittsburgh, Wexford
Health provides comprehensive healthcare services for correctional
system clients nationwide.
"More and more states are considering privatizing their prison
healthcare to private correctional managed care companies," said
Eric Larsen, CompuMed's Vice President and General Manager." He
continued, "Since these types of companies specialize in providing
great care at a better price, they validate CompuMed's value
proposition of lowered costs and high quality care through
telemedicine."
CompuMed has had the correctional ECG contract with the state of
Arizona for more than a decade but the state recently decided to
privatize their prison healthcare. Wexford Health won that bid and
contracted with CompuMed to continue and expand its services in
Arizona. CompuMed also had the ECG contract for the correctional
facilities in Maryland for many years through another partner but
the state recently decided to change their prison healthcare
provider. Wexford Health also won that bid and contracted with
CompuMed to continue priding ECG services in the Maryland DPSCS
facilities.
CompuMed's traditional core business is providing telemedicine
services such as remote ECG interpretation services to medical
facilities that may not have access to trained physicians qualified
to interpret ECG results. Customers for the Company's CardioGram
system are typically correctional facilities, ambulatory surgery
centers, occupational health clinics, rural health care providers
and physicians' offices. The system reduces healthcare costs
significantly by providing remote cardiac screening at the
point-of-care.
For information, contact CompuMed at 310-258-5000 or sales at
310-258-5033.
About CompuMed CompuMed's diagnostic and
management tools for the healthcare community focus on
telecardiology systems and software solutions. We offer analysis
and remote monitoring for patients with cardiovascular and
musculoskeletal diseases designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is
headquartered in Los Angeles and distributes its products worldwide
both directly and through OEM partners. Visit CompuMed at
www.compumed.net and follow on Twitter @compumed.
Forward-Looking Statements Statements contained in this press release
that are not historical facts, such as statements about prospective
earnings, savings, revenue, operations, revenue and earnings
growth, results of contracts and other financial results, are
forward-looking statements pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. All such
forward-looking statements including statements concerning the
Company's plans, objectives, expectations and intentions are based
largely on management's expectations and are subject to and
qualified by risks and uncertainties that could cause actual
results to differ materially from those expressed or implied by
such statements. These statements are subject to uncertainties and
risks including, without limitation, competitive factors,
outsourcing trends in the pharmaceutical industry, product and
service demand and acceptance, changes in technology, ability to
raise capital, the availability of appropriate acquisition
candidates and/or business partnerships, economic conditions, the
impact of competition and pricing, capacity and supply constraints
or difficulties, government regulation and other risks identified
in the Company's filings with the Securities and Exchange
Commission including its Annual Report on Form 10-KSB and Quarterly
Reports on Form 10-QSB. All such forward-looking statements are
expressly qualified by these cautionary statements. The Company
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements
to reflect events, conditions or circumstances on which any such
statement is based after the date hereof, except as required by
law.
Press Contact: Susan Tellem Tellem Grody Public Relations
+1 310-313-3444 susan@tellemgrodypr.com
Common Stock (PK) (USOTC:CMPD)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Common Stock (PK) (USOTC:CMPD)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024